Effettuare il login Iscriviti gratis

NeuroVive Pharmaceutical AB Margine lordo

Cos'è Margine lordo di NeuroVive Pharmaceutical AB?

Margine lordo di NeuroVive Pharmaceutical AB è -68,572.19%

Qual è la definizione di Margine lordo?



Il margine lordo è la differenza tra entrate e costo del venduto, diviso per ricavo ed espresso in percentuale.

Gross margin is a type of profit margin, specifically a form of profit divided by net revenue. It is generally calculated as the selling price of an item, minus the cost of goods sold (production or acquisition costs, not including indirect fixed costs like rent, or administrative costs). The purpose of margins is to give a description of the gross profit.

Margine lordo di aziende nel Miscellaneous settore su LSE rispetto a NeuroVive Pharmaceutical AB

Cosa fa NeuroVive Pharmaceutical AB?

Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.

Aziende con margine lordo simili a NeuroVive Pharmaceutical AB